z-logo
open-access-imgOpen Access
Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos
Author(s) -
Michael V. Zuccaro,
Jia Xu,
Carl A. Mitchell,
Diego Marín,
Raymond Zimmerman,
Bhavini Rana,
Everett Weinstein,
Rebeca T. King,
Katherine L. Palmerola,
Morgan Elizabeth Smith,
Stephen H. Tsang,
Robin Goland,
Maria Jasin,
Rogerio A. Løbo,
Nathan R. Treff,
Dieter Egli
Publication year - 2020
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2020.10.025
Subject(s) - biology , frameshift mutation , genetics , zygote , allele , mitosis , locus (genetics) , embryo , mutation , gene , embryogenesis
Correction of disease-causing mutations in human embryos holds the potential to reduce the burden of inherited genetic disorders and improve fertility treatments for couples with disease-causing mutations in lieu of embryo selection. Here, we evaluate repair outcomes of a Cas9-induced double-strand break (DSB) introduced on the paternal chromosome at the EYS locus, which carries a frameshift mutation causing blindness. We show that the most common repair outcome is microhomology-mediated end joining, which occurs during the first cell cycle in the zygote, leading to embryos with non-mosaic restoration of the reading frame. Notably, about half of the breaks remain unrepaired, resulting in an undetectable paternal allele and, after mitosis, loss of one or both chromosomal arms. Correspondingly, Cas9 off-target cleavage results in chromosomal losses and hemizygous indels because of cleavage of both alleles. These results demonstrate the ability to manipulate chromosome content and reveal significant challenges for mutation correction in human embryos.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom